Position in DYN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$248,907,468
+$87,387,662 QoQ
Shares Held
11,207,000
+25.8% QoQ
Ownership
6.00%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4
of 245 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,385 across 370 Biotechnology names. DYN ranks #58 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $248,907,447 | 11,206,999 | Shares | Sole | 2026-08-06 | |
| 2026-06-30 | $248,907,468 | 11,207,000 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $161,519,806 | 8,908,980 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $128,507,652 | 6,569,921 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $68,334,236 | 5,401,916 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $50,392,870 | 5,293,369 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $54,342,774 | 5,195,294 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $188,407,692 | 7,996,931 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $324,238,954 | 9,026,697 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $187,706,201 | 5,318,963 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $91,370,177 | 3,218,393 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $17,061,399 | 1,282,812 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,583,385 | 846,360 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $10,117,035 | 899,292 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,712,325 | 409,056 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $6,654,050 | 574,120 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $930,173 | 73,242 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $500,362 | 72,833 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $701,473 | 72,767 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $204,508 | 17,200 | Shares | Defined | 2022-02-14 | |
| 2021-03-31 | $3,284,330 | 211,483 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,469,600 | 117,600 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,374,344 | 117,600 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||